Bioresorbable Vascular Scaffolds—Dead End or Still a Rough Diamond?
نویسندگان
چکیده
منابع مشابه
Coronary bifurcations: still the touchstone of drug-eluting stents and bioresorbable vascular scaffolds?
Coronary bifurcation lesions that involve significant side branches represent a particularly challenging subset of target lesions for percutaneous coronary interventions. Besides the necessity for the interventional cardiologist to often perform technically demanding interventions with more procedural steps, clinical outcome following percutaneous coronary intervention has usually been somewhat...
متن کاملBioresorbable polymeric vascular scaffolds: a cautionary tale.
The everolimus-eluting bioresorbable vascular scaffold (BVS, Abbott Vascular, Santa Clara, CA) is an exciting advance in percutaneous coronary intervention (PCI), providing a temporary coronary scaffold for at least 3 months and being resorbed by about 2 years.1–3 Along with patient preference, potential advantages over metallic stents include restored vasomotion, reduced late thrombosis, and u...
متن کاملDelayed disruption of a bioresorbable vascular scaffold.
(A) Pre-procedural angiogram demonstrating a focal lesion at left circum previously implanted in the ostial left anterior descending artery (LAD). implantation of a 3.5 12.0 mm bioresorbable vascular scaffold (BVS) 3.5-mm noncompliant balloon. (C) The 6-month follow-up angiogram sh follow-up angiogram after gentle pre-dilation with a 2.0-mm balloon per order to obtain optical coherence tomograp...
متن کاملWhat’s in a Theorem Name? (Rough Diamond)
ITPs use names for proved theorems. Good names are either widely known or descriptive, corresponding to a theorem’s statement. Good names should be consistent with conventions, and be easy to remember. But thinking of names like this for every intermediate result is a burden: some developers avoid this by using consecutive integers or random hashes instead. We ask: is it possible to relieve the...
متن کاملBioresorbable Vascular Scaffolds for Coronary Revascularization.
Contemporary metallic drug-eluting stents are associated with very good 1-year outcomes but an ongoing risk of stent-related adverse events (thrombosis, myocardial infarction, restenosis) after 1 year. The pathogenesis of these very late events is likely related to the permanent presence of the metal stent frame or polymer. Bioresorbable scaffolds have been developed to provide drug delivery an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Medicine
سال: 2019
ISSN: 2077-0383
DOI: 10.3390/jcm8122167